Dr. Niethammer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
611 Northern Blvd
Suite 150
Great Neck, NY 11021Phone+1 516-325-7000
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2003 - 2006
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2002 - 2003
- Harvard Medical SchoolClass of 2002
Certifications & Licensure
- NY State Medical License 2005 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Publications & Presentations
PubMed
- 80 citationsLong-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s diseaseMartin Niethammer, Chris C. Tang, Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey
JCI Insight. 2017-04-06 - 166 citationsCurrent Opinions and Areas of Consensus on the Role of the Cerebellum in DystoniaVikram G. Shakkottai, Amit Batla, Kailash P. Bhatia, William T. Dauer, Christian Dresel
Cerebellum. 2017-04-01 - 7 citationsProspective F-18 FDOPA PET Imaging Study in Human PD.Vijay Dhawan, Martin H Niethammer, Martin L Lesser, Karalyn N Pappas, Matthew Hellman
Nuclear Medicine and Molecular Imaging. 2022-06-01
Press Mentions
- Diabetes Drug, Exenatide, Shows Promise Against Parkinson'sAugust 4th, 2017
- Rosacea Might Boost Parkinson’s Risk: StudyMarch 21st, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: